We have previously developed a prognostic multivariable survival model using standard and routinely accessible clinical inflammatory markers, including neutrophil and lymphocyte counts, Alb, Hb and LDH values along with p-16 tumor status [15]. Here, GSTM1 is linked to neoplasm.